• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. URETERO-RENO VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. URETERO-RENO VIDEOSCOPE Back to Search Results
Model Number URF-V2
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Sepsis (2067); Renal Impairment (4499)
Event Date 08/03/2021
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following article: "the "no-touch" technique in the flexible ureteroscopic approach of renal stones."   the present study focused on the technical aspects, advantages, drawbacks, and limitations of the latest ¿no-touch¿ technique (ntt) in the flexible ureteroscopic therapeutic approach of renal stones.A total of 288 patients with a single pyelocaliceal stone (largest diameter between 11 and 29 mm) underwent furs: 144 using the 12/14 fr uas (group 1) and 144 without uas (group 2).For ntt, used four types of ureteroscopes: olympus urf-v2 (8.5 fr) ¿ 33 cases, storz flex x2 (8.4 fr) ¿ 60 cases, single-use pusen pu 3022 (9.5 fr) ¿ 37 cases, and single-use pusen ¿ pu 3033a (7.5 fr) ¿ 14 cases.For group 1, used the olympus urf¿v2 ureteroscope in 44 cases, the storz flex x2 in 58 cases, and the single-use pusen pu 3022 in 42 cases.This study compared the operative time, hospitalization periods, and complications.Successful access sheath insertion was noted in 83.3% of cases from group 1, and successful ureteroscope insertion was noted in 90.9% of cases from group 2.The average operative time was slightly higher in group 1 vs.Group 2 (47 vs.39 min).Stone-free rates (sfrs) were overall lower in group 2 (76.3% vs.86.8%) at 1 month.Superficial mucosal ureteral wall lesions were found in 38.8% of patients from group 1 and 4.1% from group 2.Hospitalization periods were longer in group 1 vs.Group 2 (21 vs.29 hours, respectively).The single-use 7.5 fr ureteroscope should receive a special mention: the insertion was simple, we did not encounter any mucosal ureteral wall lesions, and all patients were discharged on the same day.Despite the clear advantages of routine uas usage, there are many adverse events for the patient.Larger diameter sheaths involve a greater risk of ureteral wall injury.Ntt seems to improve peri- and postoperative safety while preserving therapeutic efficiency.The new 7.5 fr ureteroscopes appear to optimize surgical efficiency and diminish complications in the flexible ureteroscopic treatment of renal stones.    type of adverse events/number of patients clavien iiia complications (4 in group 1 and 1 in group 2), renal colic requiring double j stenting (count not reported), clavien ii (15 in group 1 and 18 in group 2), sepsis - (1) ,urinary tract infections - (29), ureteral stent discomfort - (3).
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the lot number could not be confirmed at this time.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
URETERO-RENO VIDEOSCOPE
Type of Device
URETERO-RENO VIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
Manufacturer Contact
kazutaka matsumoto
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8-507
JA   192-8507
426425177
MDR Report Key14278616
MDR Text Key293695801
Report Number8010047-2022-07509
Device Sequence Number1
Product Code FGB
UDI-Device Identifier04953170343582
UDI-Public04953170343582
Combination Product (y/n)N
Reporter Country CodeRO
PMA/PMN Number
K172246
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberURF-V2
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/10/2022
Initial Date FDA Received05/04/2022
Supplement Dates Manufacturer Received06/06/2022
Supplement Dates FDA Received06/29/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-